BTBriac Thierry

Briac Thierry

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Briac Thierry has a total of 315 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • International Pediatric Otolaryngology Group (IPOG) consensus recommendations: Management of the pediatric thyroglossal duct cyst

    by Samantha Goh, John Maddalozzo, Matthew Brigger, Khadijah Bt Mohd Nor, Neil Chadha, Alan Cheng, Michael J. Cunningham, Sam Daniel, Ari DeRowe, Bee See Goh, et al.

  • Does the inferior facial angle predict respiratory status in Robin sequence infants?

    by Maëlys Léger, David Grevent, Romain Luscan, Brigitte Fauroux, Andrea Talla, Laurent J. Salomon, Agnès Giuseppi, Nancy Vegas, Véronique Abadie, Briac Thierry

    Robin sequence (RS) is a rare congenital condition characterized by retrognathia, glossoptosis, and upper airway obstruction, with highly variable respiratory severity at birth. Prenatal measurement of the inferior facial angle (IFA) is used to support diagnosis, but its prognostic value for respiratory outcomes remains uncertain. This study assessed whether fetal MRI–measured IFA predicts early respiratory status in infants with RS. We conducted a retrospective monocentric study including consecutive infants with prenatal suspicion and postnatal confirmation of RS who underwent fetal MRI between 2009 and 2021. Respiratory status was assessed at delivery and at 6 months and categorized as room air breathing, noninvasive respiratory support, or intubation/tracheostomy. Five blinded operators independently measured the IFA and the anteroposterior skull size (APSS) on median sagittal MRI slice. Interobserver agreement was evaluated using intraclass correlation coefficients. Potential predictors of respiratory outcomes were analyzed using ordinal logistic regression. Among 43 infants, 72% required respiratory support at birth. More than half required ongoing respiratory assistance during early infancy. IFA values did not differ across respiratory outcome categories and were not associated with respiratory status at birth or during follow-up. Interobserver reliability was poor for IFA measurements, whereas APSS showed excellent agreement. In multivariable analyses, higher gestational age at birth was the only factor associated with reduced respiratory morbidity during the first 6 months. Conclusion: These findings indicate that, although IFA is useful for diagnosing RS, it lacks reproducibility and prognostic value for respiratory outcomes, highlighting the need for delivery in specialized centers. What is Known: • In Pierre Robin sequence, no reliable prenatal predictor of respiratory status at birth exists. Although the inferior facial angle is used for prenatal diagnosis, its ability to predict neonatal respiratory severity is unknown. What is New: • The inferior facial angle in prenatal fetal MRI shows limited predictive value for respiratory status at birth and during early infancy in infants with Robin sequence, with substantial measurement variability reducing its reliability as an isolated prognostic imaging marker.

  • Remplacement trachéal pédiatrique : développement d'une matrice trachéale décellularisée par ingénierie tissulaire et évaluation de la biocompatibilité dans un modèle porcin

    by Briac Thierry

    La mise au point d'un substitut trachéal permettant des remplacements circonférentiels étendus de la trachée reste un des plus grands défis de la chirurgie des voies aériennes. Chez l'enfant, plusieurs pathologies trachéales congénitales non tumorales en échec de traitement pourraient bénéficier d'un remplacement trachéal circonférentiel étendu. Il n'y a pas de consensus clinique sur la stratégie à adopter entre les différents substituts proposés : allotransplantation, allogreffe aortique, reconstruction chirurgicale par lambeau libre, trachée décellularisée. La décellularisation trachéale est une technique d'ingénierie tissulaire qui élimine les cellules pour obtenir une matrice biocompatible et faiblement immunogène, en préservant les propriétés biochimiques et biomécaniques de la matrice extracellulaire. La notion spécifique à la trachée de compartiments d'antigénicité distincts, différenciant le pouvoir antigénique du cartilage de celui de la muqueuse, a permis l'émergence du concept de décellularisation partielle, qui permet de conserver au mieux ces propriétés biomécaniques. Nous avons développé un processus de fabrication de matrice trachéale partiellement décellularisée (MTD) à partir d'une trachée porcine. Cette étude a été menée dans l'esprit d'une recherche translationnelle : nous avons utilisé des produits de grade clinique pour le protocole de décellularisation et nous avons utilisé un modèle porcin, pour des raisons de similitudes anatomiques et immunologiques avec l'homme. La caractérisation de la MTD obtenue a démontré qu'elle est conforme aux principes de la décellularisation : en histologie et en microscopie électronique à balayage (MEB), la MTD ne contient plus de cellules dans la muqueuse et dans la sous-muqueuse ; le dosage de l'ADN résiduel de la muqueuse trachéale est inférieur à 50ng/mg ; il n'y a plus de fragments d'ADN de plus de 200 paires de bases. A la fin du protocole de décellularisation, qui inclut une phase de détoxification, la MTD ne relargue aucun agent cytotoxique. In vitro, nous avons montré que des cellules épithéliales peuvent proliférer sur la MTD. Ces résultats démontrent l'efficacité de la décellularisation et l'absence de cytotoxicité résiduelle. De plus, toutes les MTD n'étaient stériles, dès le traitement par des antibiotiques/antimycotique, après décellularisation et cryopréservation. Nous avons développé un test objectif de caractérisation biomécanique associant imagerie par tomodensitométrie concomitamment à l'application de contraintes mécaniques par variations physiologiques cycliques de pression. Les caractéristiques des MTD sont similaires à celles de trachées natives. Nous avons évalué la biocompatibilité de ces MTD in vivo dans un modèle porcin durant la phase d'implantation musculaire, qui est la première phase du remplacement trachéal. Cette étape préliminaire a pour objectif la néovascularisation et la colonisation cellulaire. Les MTD n'ont pas entrainé de réaction inflammatoire systémique. Les études histologiques ont permis de montrer qu'elles sont colonisées par de nombreux myofibroblastes, et que la sous-muqueuse est le siège d'une néovascularisation intense. Aucun infiltrat lymphocytaire, ni de nécrose musculaire n'a été observé 28 jours après l'implantation de la MTD. Macroscopiquement, la biomécanique des trachées apparait préservée. En conclusion, nos résultats montrent que les MTD sont biocompatibles in vivo, et qu'elles n'entrainent pas de rejet de greffe. Ces études de la qualité et de la conformité des MTD après un processus d'ingénierie tissulaire représentent des étapes décisives en vue d'une application chez l'homme.

  • Open Access

    Biointegration of a partially decellularized tracheal scaffold in a porcine model - preliminary results

    by Augustin Vigouroux, Yannis Bonnin, Nicolas Gendron, Sabrina Kellouche, Rémy Agniel, Patrick Bruneval, Daniel Balvay, Jean-Marc Allain, Stéphanie Chhun, Hervé Kempf, et al.

    Some pediatric tracheal pathologies remain therapeutic dead ends for which current palliative strategies are fraught with serious complications. With the aim of a tracheal replacement, our team has previously developed and patented a clinical grade partially decellularized trachea (PDT) from porcine tracheas. The aim of this work was to study and compare the biointegration mechanisms of this PDT in vivo , in a pig cervical muscle, with or without immunosuppressant. The secondary objective was to evaluate the optimal maturation time of the PDT in this heterotopic position. In total, 11 female Large White/Landrace pigs, weighing between 50 and 70 kg were included in this study. The mean age of the animals at the implantation was 4.8 months. The PDTs were implanted in a cervical muscle of pigs for either 28 days, with or without cyclosporin A treatment, or for 56 days without immunosuppression. Histological evaluation showed very good PDT biointegration, characterized by neovascularization and fibroblast colonization, and no detectabale infection. Additionally, tissue and blood analyses showed no signs of graft rejection or surrounding tissue necrosis. Immunosuppression did not show any superiority in terms of biointegration after 28 days of treatment. After 56 days of implantation, a more significant degradation of the cartilage. Therefore, the optimal condition for PDT maturation proved to be 28 days, without immunosuppression.


  • Open Access

    Outcome of Esophageal Atresia: What Choice of Suture Material?

    by Nina Martz, Véronique Rousseau, Alexandre Lapillonne, Briac Thierry, Florence Campeotto, Sylvie Beaudoin


  • Open Access

    The Development of a European Registry for Facial Dysostosis Syndromes: A Delphi-Guided Approach

    by Victor L. PhD van Roey, Saranda Ombashi, Irene M.J. Mathijssen, Åsa A. Msc Munkhammar, Pamela M. Bsc Åsten, Anouar Bouzariouh, Charlotte Célérier, Caroline Dana, Marieke van Dooren, Mariët Msc Faasse, et al.

    Facial dysostosis syndromes (FDS) are rare congenital conditions that significantly impact facial function and appearance. At the time of this writing, standardised monitoring protocols for FDS are lacking, hampering research, and evidence-based care. Thus, a comprehensive dataset was developed within the European Reference Network for Rare and Complex Craniofacial Anomalies (ERN CRANIO). Candidate data elements were identified through a systematic literature review (1985–2024) and supplemented with elements from existing ERN CRANIO datasets and expert panel suggestions. A Delphi survey was then conducted among 61 clinicians and 3 patient representatives to assess each element’s relevance and reliability using a 9-point Likert scale. A subsequent hybrid consensus meeting with the expert panel shaped the final dataset, ensuring comprehensive coverage, avoiding overlap, and determining the appropriate timing for data collection. Of 200 data elements that entered the Delphi voting, 98 were strongly recommended, 102 scored neutral, and none were strongly discouraged. Ultimately, 110 elements were included, organised into 2 levels: Level 1, comprising exclusively patient-reported and parent-reported outcome measures; and Level 2, encompassing patient characteristics, treatment information, clinical outcomes, and imaging/diagnostics. This newly developed dataset marks the first international registry for FDS, offering considerable potential for collaborative research, cross-centre comparisons, and substantial improvements in care for patients with FDS worldwide. Real-world implementation will be essential to evaluate its feasibility and guide further refinements.


  • Endoscopic Anteroposterior Cricoid Split in Idiopathic Bilateral Vocal Fold Immobility in Newborns: A Consecutive Case Series

    by Emilien Chebib, Romain Luscan, Vincent Couloigner, Nicolas Leboulanger, Briac Thierry

    Objective: The objective of this study was to evaluate the efficacy of endoscopic anteroposterior cricoid split (APCS) in the management of congenital idiopathic bilateral vocal fold immobility (ciBVFI).Methods: In this retrospective monocentric study, all patients who underwent APCS for ciBVFI between January 2017 and December 2022 were included. APCS was indicated in case of failure to wean off non‐invasive ventilation (NIV) or in cases requiring intubation. Surgical success was defined as the absence of tracheotomy or laryngoplasty at the end of follow‐up, as well as a satisfactory respiratory status without exertional dyspnea over a minimum follow‐up period of 18 months post surgery.Results: Sixteen children, including 11 boys (69%), were included. The mean follow‐up period was 52.4 ± 22.0 months. The mean age at APCS was 1.7 ± 1.9 months. Among the seven children of the success group (44%), all (7/7, 100%) regained vocal fold mobility. The mean recovery time was 12 ± 11 months (p = 0.003). In the failure group (n = 9), eight patients (89%) underwent tracheotomy at the age of 3.8 ± 4.6 months. The balloon dilatation diameter was statistically different between the successful and failure groups (p = 0.003). The outer diameter of the stenting intubation tube, duration of postoperative intubation, and performance of follow‐up endoscopies were not significantly different.Conclusion: APCS is a straightforward technique that has a role to play in the surgical treatment of ciBVFI. It enables a watchful waiting approach to allow spontaneous recovery of vocal fold mobility, thus avoiding invasive procedures such as early tracheostomy or laryngoplasty.Level of Evidence: 4.


  • Full circumferential human tracheal replacement: a systematic review

    by Briac Thierry, Lousineh Arakelian, Françoise Denoyelle, Jérôme Larghero, Alain Wurtz

    Full Circumferential Tracheal Replacement (FCTR) is a surgical challenge, indicated in rare cases of extensive tracheal resection, with no consensus on surgical technique or materials. A systematic review according to PRISMA guidelines was carried out from 2000 to 2022 to identify cases of FCTR, to compare surgical indications, the nature of the tracheal substitutes and their immunological characteristics, surgical replacement techniques and vascularization. Thirty-seven patients, including five children, underwent FCTR surgery using 4 different techniques: thyrotracheal complex allograft (n = 2), aorta (n = 12), autologous surgical reconstruction (n = 19), tissue-engineered decellularized trachea (n = 4). The mean follow-up was 4 years. Of the 15 deceased patients, 10 died of the progression of the initial pathology. For the majority of the teams, particular care was given to the vascularization of the substitute, in order to guarantee long-term biointegration. This included either direct vascularization via vascular anastomosis, or an indirect technique involving envelopment of the avascular substitute in a richly vascularized tissue. Stent placement was standard, except for autologous surgical reconstructions where tracheal caliber was stable. Internal stents were frequently complicated by granulation and stenosis. Although epithelial coverage is essential to limit endoluminal proliferation and act as a barrier, fully functional ciliated airway epithelium did not seem to be necessary. In order to facilitate future comparisons, a standardized clinical trial, respecting regulatory constraints, including routine follow-up with tracheal biomechanics assessment and scheduled biopsies could be proposed. It would help collecting information such as dynamics and mechanisms of tracheal bio-integration and regeneration.